As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
SALE
|
|
|
|
|
|
|
|
|
Market Outlook
The global haemato oncology testing market is forecast to reach USD 4.6 billion by 2025 from USD 1.8 billion in 2019, growing at a CAGR of 17% over the forecast period of 2020-2025.
Get a Free Sample Report with Table of Contents - Download Now
Haematological malignancies are among the top ten malignant disorders in terms of incidence rate and cause of death in cancer patients. They collectively make up about 9% of all cancer cases diagnosed in a year. Geneticists provide not only diagnostic tests to haemato oncologists, but also key knowledge of cancer genetics that helps the specialists evaluate their patient’s prognosis, select the most appropriate anticancer therapy, and monitor treatment response.
Properties and Applications
Haemato oncology testing is a test that aids in the diagnosis of blood disease (haematology) and cancer (oncology), further supporting the treatment and prevention of the disease, and providing research into them. Haematology-oncology includes diseases such as iron deficiency anaemia, haemophilia, sickle cell disease, thalassemia, leukaemia, and other organ cancers.
The haemato oncology testing industry can be divided based on segments like cancer type, technology, and application.
The industry can be divided based on cancer type as:
The industry can be divided based on technology as PCR, IHC, NGS, and cytogenetics, among others.
The industry can be broadly categorised based on application into:
The EMR report looks into the regional markets of haemato oncology testing like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Market Analysis
The global haemato oncology testing market is driven by haematological cancer’s increasing global prevalence, increasing awareness of personalized medicines, and increasing collaborations to develop new assays. On the other hand, it is expected that an uncertain reimbursement scenario will restrict the growth of this market during the forecast period in various regions.
The services segment represents the largest proportion of haemato oncology testing. This is mainly due to the growing prevalence and incidence of leukaemia, non-Hodgkin lymphoma, and cancer of myeloma. In addition, the growing awareness of advanced therapies such as personalized medicine also drives this segment’s growth. The growth in the Asia Pacific market is driven primarily by the large patient population, and a growing focus on expanding in this region will drive the industry growth.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global haemato oncology testing market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Questions Answered in the Market Report:
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Haemato Oncology Testing Market Analysis
6.1 Global Haemato Oncology Testing Market (2015-2019) & Forecast (2020-2025)
6.2 Global Haemato Oncology Testing Market Breakup by Cancer Type
6.2.1 Laeukemia
6.2.2 Lymphoma
6.2.3 Hodgkin Lymphoma
6.2.4 Others
6.3 Global Haemato Oncology Testing Market Breakup by Cancer Type Historical Market (2015-2019) & Forecast (2020-2025)
6.3.1 Laeukemia
6.3.2 Lymphoma
6.3.3 Hodgkin Lymphoma
6.3.4 Others
6.4 Global Haemato Oncology Testing Market Breakup by Technology
6.4.1 PCR
6.4.2 IHC
6.4.3 NGS
6.4.4 Cytogenetics
6.4.5 Others
6.5 Global Haemato Oncology Testing Market Breakup by Technology: Historical Market (2015-2019) & Forecast (2020-2025)
6.5.1 PCR
6.5.2 IHC
6.5.3 NGS
6.5.4 Cytogenetics
6.5.5 Others
6.6 Global Haemato Oncology Testing Market Breakup by Application
6.6.1 Clinical Laboratories
6.6.2 Hospitals
6.6.3 Academic & Research Institutes
6.6.4 Others
6.7 Global Haemato Oncology Testing Market Breakup by Application: Historical Market (2015-2019) & Forecast (2020-2025)
6.7.1 Clinical Laboratories
6.7.2 Hospitals
6.7.3 Academic & Research Institutes
6.7.4 Others
6.8 Global Haemato Oncology Testing Market Breakup by Region
6.8.1 North America
6.8.1.1 United States of America
6.8.1.2 Canada
6.8.2 Europe
6.8.2.1 Germany
6.8.2.2 United Kingdom
6.8.2.3 France
6.8.2.4 Italy
6.8.2.5 Others
6.8.3 Asia Pacific
6.8.3.1 China
6.8.3.2 Japan
6.8.3.3 India
6.8.3.4 ASEAN
6.8.3.5 Others
6.8.4 Latin America
6.8.4.1 Brazil
6.8.4.2 Argentina
6.8.4.3 Mexico
6.8.4.4 Others
6.8.5 Middle East & Africa
6.8.5.1 Saudi Arabia
6.8.5.2 United Arab Emirates
6.8.5.3 Nigeria
6.8.5.4 South Africa
6.8.5.5 Others
6.9 Global Haemato Oncology Testing Market Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
6.9.1 North America
6.9.1.1 United States of America
6.9.1.2 Canada
6.9.2 Europe
6.9.2.1 Germany
6.9.2.2 United Kingdom
6.9.2.3 France
6.9.2.4 Italy
6.9.2.5 Others
6.9.3 Asia Pacific
6.9.3.1 China
6.9.3.2 Japan
6.9.3.3 India
6.9.3.4 ASEAN
6.9.3.5 Others
6.9.4 Latin America
6.9.4.1 Brazil
6.9.4.2 Argentina
6.9.4.3 Mexico
6.9.4.4 Others
6.9.5 Middle East & Africa
6.9.5.1 Saudi Arabia
6.9.5.2 United Arab Emirates
6.9.5.3 Nigeria
6.9.5.4 South Africa
6.9.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 Competitive Landscape & Supplier Analysis
9.1 F. Hoffmann-La Roche Ltd. [Roche Holding AG]
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 Abbott [ABT (NYSE)]
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Qiagen [QGEN (NYSE)]
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 Thermo Fisher Scientific Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Illumina, Inc. [ILMN (NASDAQ)]
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 Bio-Rad Laboratories, Inc. [BIO (NYSE)]
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 MolecularMD [ICON plc]
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 ArcherDX, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Arup Laboratories
9.9.1 Company Overview
9.9.2 Financial Analysis
9.10 Asuragen, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.11 Others
10 Events and Development
EMR is one of the foremost business intelligence and market research firms with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each market and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with market insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
Our approach gives our clients a comprehensive assessment of the prevailing and projected market conditions through the collection, collation, and analysis of data from trusted sources.
Price Assessment
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable market strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Market Assessment
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future market growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the market.
Primary Research
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
Secondary Research
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing market conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the market, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and market strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the market, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the market space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Cannabis refers to a psychoactive medication extracted from the Cannabaceae family cannabis plant. The drug was used in ancient Indian, Chinese, Egyptian as well as Islamic cultures. These days, canna...
The global tumour necrosis factor inhibitor drugs market attained a value of around USD 40.3 billion in 2019. The market is further expected to grow in the forecast period of 2020-2025 at a CAGR of ar...
The global uveitis drugs market is estimated to grow at a CAGR of almost 6.8% in the forecast period of 2020-2025. The global uveitis drugs market is being driven by the increased prevalence of eye di...
The global obsessive-compulsive disorder drugs market is projected to grow at a CAGR of almost 4.8% over the forecast period of 2020-2025. The global obsessive-compulsive disorder drugs market is bein...
The global sinusitis drugs market is expected to grow in the forecast period of 2020-2025 at a CAGR of more than 5.5%. The prevalence of sinus infection among adults and children is growing. Among the...
Buy Full Version
"Haemato Oncology Testing Market"
Purchase Enquiry